Addition of tiotropium to formoterol improves inspiratory muscle strength after exercise in COPD
Autor(a) principal: | |
---|---|
Data de Publicação: | 2012 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNIFESP |
dARK ID: | ark:/48912/001300000g8p8 |
Texto Completo: | http://dx.doi.org/10.1016/j.rmed.2012.05.012 http://repositorio.unifesp.br/handle/11600/35301 |
Resumo: | Background: the addition of tiotropium bromide (110) to formoterol fumarate (FOR) improves exercise performance in patients with chronic obstructive pulmonary disease (COPD). in this study, we test the hypothesis that the addition of TIO to for may improve respiratory muscle performance and oxygen uptake kinetics after exercise in patients with COPD.Methods: Thirty eight patients with COPD were randomized to a 2 week treatment with for 12 mu g twice a day plus TIO 18 mu g once a day (FOR + TIO) or for 12 mu g twice a day plus placebo (FOR + PLA) once a day, using a double-blind crossover design. Inspiratory muscle. Strength was measured before, immediately after, as well as 2, 5, and 10 min during recovery of exercise. Time to limit of tolerance on a constant work load exercise test and oxygen uptake kinetics during recovery were evaluated before and after intervention.Results: Only for + TIO improved resting (63 +/- 10 cm to 84 +/- 11 cmH(2)O) and post-exercise (49 +/- 7 cm to 84 +/- 11 cmH(2)O) maximal inspiratory pressure. Time to limit of tolerance on the constant work load test was increased by for + PLA and by for + TIO, but the size of the increment was significantly larger with for + TIO (40.7 +/- 7.6% vs. 84.5 +/- 8.2%; p < 0.05). Only for + TIO improved oxygen uptake kinetics during recovery (69 +/- 21 to 60 +/- 18s). the improvement in maximal inspiratory pressure (0.78, p < 0.001) and in oxygen uptake kinetics (-0.91, p < 0.001) correlated with the change in time to the limit of tolerance.Conclusions: the addition of TIO to for improves inspiratory muscle strength and oxygen uptake kinetics after exercise in COPD patients. (C) 2012 Elsevier B.V. All rights reserved. |
id |
UFSP_55949b873d08c15381a295f6f8298389 |
---|---|
oai_identifier_str |
oai:repositorio.unifesp.br/:11600/35301 |
network_acronym_str |
UFSP |
network_name_str |
Repositório Institucional da UNIFESP |
repository_id_str |
3465 |
spelling |
Addition of tiotropium to formoterol improves inspiratory muscle strength after exercise in COPDRespiratory musclesOxygenInspiratory muscle strengthConstant work testBackground: the addition of tiotropium bromide (110) to formoterol fumarate (FOR) improves exercise performance in patients with chronic obstructive pulmonary disease (COPD). in this study, we test the hypothesis that the addition of TIO to for may improve respiratory muscle performance and oxygen uptake kinetics after exercise in patients with COPD.Methods: Thirty eight patients with COPD were randomized to a 2 week treatment with for 12 mu g twice a day plus TIO 18 mu g once a day (FOR + TIO) or for 12 mu g twice a day plus placebo (FOR + PLA) once a day, using a double-blind crossover design. Inspiratory muscle. Strength was measured before, immediately after, as well as 2, 5, and 10 min during recovery of exercise. Time to limit of tolerance on a constant work load exercise test and oxygen uptake kinetics during recovery were evaluated before and after intervention.Results: Only for + TIO improved resting (63 +/- 10 cm to 84 +/- 11 cmH(2)O) and post-exercise (49 +/- 7 cm to 84 +/- 11 cmH(2)O) maximal inspiratory pressure. Time to limit of tolerance on the constant work load test was increased by for + PLA and by for + TIO, but the size of the increment was significantly larger with for + TIO (40.7 +/- 7.6% vs. 84.5 +/- 8.2%; p < 0.05). Only for + TIO improved oxygen uptake kinetics during recovery (69 +/- 21 to 60 +/- 18s). the improvement in maximal inspiratory pressure (0.78, p < 0.001) and in oxygen uptake kinetics (-0.91, p < 0.001) correlated with the change in time to the limit of tolerance.Conclusions: the addition of TIO to for improves inspiratory muscle strength and oxygen uptake kinetics after exercise in COPD patients. (C) 2012 Elsevier B.V. All rights reserved.Hosp Clin Porto Alegre, Exercise Pathophysiol Res Lab, Porto Alegre, RS, BrazilHosp Clin Porto Alegre, Div Cardiol, Porto Alegre, RS, BrazilUniv So Santa Catarina, Exercise Biochem & Physiol Lab, Postgrad Program Hlth Sci, Hlth Sci Unit, Criciuma, BrazilUniv Fed Rio Grande do Sul, Dept Med, Fac Med, Porto Alegre, RS, BrazilUniversidade Federal de São Paulo, Pulm Funct & Clin Exercise Physiol Unit SEFICE, Div Resp, Dept Med, São Paulo, BrazilPaulista Sch Med UNIFESP EPM, São Paulo, BrazilUniversidade Federal de São Paulo, Pulm Funct & Clin Exercise Physiol Unit SEFICE, Div Resp, Dept Med, São Paulo, BrazilPaulista Sch Med UNIFESP EPM, São Paulo, BrazilWeb of ScienceConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)W B Saunders Co LtdHosp Clin Porto AlegreUniv So Santa CatarinaUniv Fed Rio Grande do SulUniversidade Federal de São Paulo (UNIFESP)Canto, Nívea Dias doRibeiro, Jorge PintoNeder, José Alberto [UNIFESP]Chiappa, Gaspar Rogério da2016-01-24T14:27:44Z2016-01-24T14:27:44Z2012-10-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion1404-1412application/pdfhttp://dx.doi.org/10.1016/j.rmed.2012.05.012Respiratory Medicine. London: W B Saunders Co Ltd, v. 106, n. 10, p. 1404-1412, 2012.10.1016/j.rmed.2012.05.012WOS000309147400008.pdf0954-6111http://repositorio.unifesp.br/handle/11600/35301WOS:000309147400008ark:/48912/001300000g8p8engRespiratory Medicineinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-08-01T02:55:28Zoai:repositorio.unifesp.br/:11600/35301Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-12-11T20:16:36.452688Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false |
dc.title.none.fl_str_mv |
Addition of tiotropium to formoterol improves inspiratory muscle strength after exercise in COPD |
title |
Addition of tiotropium to formoterol improves inspiratory muscle strength after exercise in COPD |
spellingShingle |
Addition of tiotropium to formoterol improves inspiratory muscle strength after exercise in COPD Canto, Nívea Dias do Respiratory muscles Oxygen Inspiratory muscle strength Constant work test |
title_short |
Addition of tiotropium to formoterol improves inspiratory muscle strength after exercise in COPD |
title_full |
Addition of tiotropium to formoterol improves inspiratory muscle strength after exercise in COPD |
title_fullStr |
Addition of tiotropium to formoterol improves inspiratory muscle strength after exercise in COPD |
title_full_unstemmed |
Addition of tiotropium to formoterol improves inspiratory muscle strength after exercise in COPD |
title_sort |
Addition of tiotropium to formoterol improves inspiratory muscle strength after exercise in COPD |
author |
Canto, Nívea Dias do |
author_facet |
Canto, Nívea Dias do Ribeiro, Jorge Pinto Neder, José Alberto [UNIFESP] Chiappa, Gaspar Rogério da |
author_role |
author |
author2 |
Ribeiro, Jorge Pinto Neder, José Alberto [UNIFESP] Chiappa, Gaspar Rogério da |
author2_role |
author author author |
dc.contributor.none.fl_str_mv |
Hosp Clin Porto Alegre Univ So Santa Catarina Univ Fed Rio Grande do Sul Universidade Federal de São Paulo (UNIFESP) |
dc.contributor.author.fl_str_mv |
Canto, Nívea Dias do Ribeiro, Jorge Pinto Neder, José Alberto [UNIFESP] Chiappa, Gaspar Rogério da |
dc.subject.por.fl_str_mv |
Respiratory muscles Oxygen Inspiratory muscle strength Constant work test |
topic |
Respiratory muscles Oxygen Inspiratory muscle strength Constant work test |
description |
Background: the addition of tiotropium bromide (110) to formoterol fumarate (FOR) improves exercise performance in patients with chronic obstructive pulmonary disease (COPD). in this study, we test the hypothesis that the addition of TIO to for may improve respiratory muscle performance and oxygen uptake kinetics after exercise in patients with COPD.Methods: Thirty eight patients with COPD were randomized to a 2 week treatment with for 12 mu g twice a day plus TIO 18 mu g once a day (FOR + TIO) or for 12 mu g twice a day plus placebo (FOR + PLA) once a day, using a double-blind crossover design. Inspiratory muscle. Strength was measured before, immediately after, as well as 2, 5, and 10 min during recovery of exercise. Time to limit of tolerance on a constant work load exercise test and oxygen uptake kinetics during recovery were evaluated before and after intervention.Results: Only for + TIO improved resting (63 +/- 10 cm to 84 +/- 11 cmH(2)O) and post-exercise (49 +/- 7 cm to 84 +/- 11 cmH(2)O) maximal inspiratory pressure. Time to limit of tolerance on the constant work load test was increased by for + PLA and by for + TIO, but the size of the increment was significantly larger with for + TIO (40.7 +/- 7.6% vs. 84.5 +/- 8.2%; p < 0.05). Only for + TIO improved oxygen uptake kinetics during recovery (69 +/- 21 to 60 +/- 18s). the improvement in maximal inspiratory pressure (0.78, p < 0.001) and in oxygen uptake kinetics (-0.91, p < 0.001) correlated with the change in time to the limit of tolerance.Conclusions: the addition of TIO to for improves inspiratory muscle strength and oxygen uptake kinetics after exercise in COPD patients. (C) 2012 Elsevier B.V. All rights reserved. |
publishDate |
2012 |
dc.date.none.fl_str_mv |
2012-10-01 2016-01-24T14:27:44Z 2016-01-24T14:27:44Z |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1016/j.rmed.2012.05.012 Respiratory Medicine. London: W B Saunders Co Ltd, v. 106, n. 10, p. 1404-1412, 2012. 10.1016/j.rmed.2012.05.012 WOS000309147400008.pdf 0954-6111 http://repositorio.unifesp.br/handle/11600/35301 WOS:000309147400008 |
dc.identifier.dark.fl_str_mv |
ark:/48912/001300000g8p8 |
url |
http://dx.doi.org/10.1016/j.rmed.2012.05.012 http://repositorio.unifesp.br/handle/11600/35301 |
identifier_str_mv |
Respiratory Medicine. London: W B Saunders Co Ltd, v. 106, n. 10, p. 1404-1412, 2012. 10.1016/j.rmed.2012.05.012 WOS000309147400008.pdf 0954-6111 WOS:000309147400008 ark:/48912/001300000g8p8 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Respiratory Medicine |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
1404-1412 application/pdf |
dc.publisher.none.fl_str_mv |
W B Saunders Co Ltd |
publisher.none.fl_str_mv |
W B Saunders Co Ltd |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UNIFESP instname:Universidade Federal de São Paulo (UNIFESP) instacron:UNIFESP |
instname_str |
Universidade Federal de São Paulo (UNIFESP) |
instacron_str |
UNIFESP |
institution |
UNIFESP |
reponame_str |
Repositório Institucional da UNIFESP |
collection |
Repositório Institucional da UNIFESP |
repository.name.fl_str_mv |
Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP) |
repository.mail.fl_str_mv |
biblioteca.csp@unifesp.br |
_version_ |
1818602460212625408 |